220 related articles for article (PubMed ID: 11896820)
1. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
Kumamoto H; Yoshida M; Ooya K
J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas.
Kumamoto H; Kimi K; Ooya K
J Oral Pathol Med; 2001 Nov; 30(10):596-602. PubMed ID: 11722709
[TBL] [Abstract][Full Text] [Related]
4. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
5. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63 and p73 in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
[TBL] [Abstract][Full Text] [Related]
7. Expression of inducible nitric oxide synthase and vascular endothelial growth factor in ameloblastoma.
Chen WL; Ouyang KX; Li HG; Huang ZQ; Li JS; Wang JG
J Craniofac Surg; 2009 Jan; 20(1):171-5; discussion 176-7. PubMed ID: 19165019
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
Kumamoto H; Ooya K
Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and microvessel density around healthy and failing dental implants.
Cornelini R; Artese L; Rubini C; Fioroni M; Ferrero G; Santinelli A; Piattelli A
Int J Oral Maxillofac Implants; 2001; 16(3):389-93. PubMed ID: 11432658
[TBL] [Abstract][Full Text] [Related]
15. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
Kumamoto H; Takahashi N; Ooya K
J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
[TBL] [Abstract][Full Text] [Related]
16. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
Kumamoto H; Ohki K
J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs) in ameloblastomas.
Kumamoto H; Suzuki T; Ooya K
J Oral Pathol Med; 2002 Nov; 31(10):605-11. PubMed ID: 12406306
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of BH3-only proteins in ameloblastic tumors.
Kumamoto H; Ooya K
Oral Dis; 2008 Sep; 14(6):550-5. PubMed ID: 18826384
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
